Cargando…
Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer
OBJECTIVE: Recently, 14-3-3 zeta protein was identified as a potential serum biomarker of epithelial ovarian cancer (EOC). The goal of this study was to investigate the clinical potential of 14-3-3 zeta protein for monitoring EOC progression compared with CA-125 and HE4. DESIGN: Prospective follow-u...
Autores principales: | Hatzipetros, Ioannis, Gocze, Peter, Koszegi, Tamas, Jaray, Akos, Szereday, Laszlo, Polgar, Beata, Farkas, Nelli, Farkas, Balint |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835546/ https://www.ncbi.nlm.nih.gov/pubmed/24238270 http://dx.doi.org/10.1186/1757-2215-6-79 |
Ejemplares similares
-
Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy
por: Hatzipetros, Ioannis, et al.
Publicado: (2013) -
Peripheral Blood TIM-3 Positive NK and CD8+ T Cells throughout Pregnancy: TIM-3/Galectin-9 Interaction and Its Possible Role during Pregnancy
por: Meggyes, Matyas, et al.
Publicado: (2014) -
Diagnostic relevance of urinary steroid profiles on ovarian granulosa cell tumors: two case reports
por: Bufa, Anita, et al.
Publicado: (2017) -
The immunological effect of Galectin-9/TIM-3 pathway after low dose Mifepristone treatment in mice at 14.5 day of pregnancy
por: Lajko, Adrienn, et al.
Publicado: (2018) -
The importance of the PD-1/PD-L1 pathway at the maternal-fetal interface
por: Meggyes, Matyas, et al.
Publicado: (2019)